What is Lupride Depot 22.50 mg?
Lupride Depot 22.50mg Injection is used in the treatment of prostate cancer. It is also used to treat endometriosis (endometrium of the uterus grows excessively and causes symptoms like pain, heavy or irregular periods), uterine fibroids and central precocious puberty (very early puberty).
Lupride Depot 22.50mg Injection is given as an injection under the skin by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Benefits of Lupride Depot 22.50 mg
How to use Lupride Depot 22.50 mg?
How to work Lupride Depot 22.50 mg?
What if you forget to take Lupride Depot 22.50 mg?
Side effects of Lupride Depot 22.50 mg
- Decreased libido
- Testicular atrophy
- Increased sweating
- Muscle weakness
- Erectile dysfunction
- Bone pain
- Injection site reaction
- Hot flashes
1. Is Lupride Depot 22.50mg Injection a chemotherapy medicine?
2. Does Lupride Depot 22.50mg Injection stop periods?
Yes, the periods tend to stop while taking Lupride Depot 22.5mg Injection injections as this medicine alters the reproductive hormones in females. Sometimes, there can be vaginal bleeding in a few cases. If this occurs, please contact your doctor to get yourself assessed and follow the direction of your doctor.
3. Is Lupride Depot 22.50mg Injection a hormonal medicine and can it be given in pregnancy?
4. Can taking Lupride Depot 22.50mg Injection affect my bones?
Yes, there are chances of Lupride Depot 22.50mg Injection affecting your bones. Using Lupride Depot 22.5mg Injection may cause a decrease in bone mineral density and make the bones weaker. In women, bone density should be assessed before starting the treatment. Special care and monitoring should be done in women with increased risk of osteoporosis. If at all needed, additional medicines may be given to prevent the development of osteoporosis in patients with decreased bone mineral density.